Nel ASA’s €135 Million EU Boost Buys Time, but Conviction is Missing

Nel ASA surges 86% in 2025 on new alkaline electrolyser technology and €135M EU grant, but analysts see 40% downside with no buy ratings and weak Q1 orders.

The Norwegian hydrogen specialist Nel ASA has stormed to a fresh 52-week high of €0.36, yet the rally stands on remarkably shaky analytical ground. While the stock has surged roughly 86% since January and gained nearly 62% in the past month alone, Wall Street’s verdict is anything but bullish: the average price target hovers around €0.22, not a single analyst recommends buying, and seven rate the shares a sell. The gap between market enthusiasm and professional scepticism has rarely looked wider.

The trigger for the latest leg up is a technological breakthrough Nel rolled out in early May after more than eight years of development. The new pressurised alkaline electrolyser platform promises to slash system investment costs by 40% to 60% compared with current industry solutions. For a 25?megawatt project, Nel targets turnkey costs below $1,450 per kilowatt — less than half the prevailing market rate of roughly $3,000. The modules are pre?assembled in the factory, cutting construction risk and shortening project timelines. If the cost numbers hold up, the platform could rewrite the economics of green hydrogen production.

The expansion plan to back that promise has received a powerful financial tailwind. The European Union’s Innovation Fund has awarded Nel up to €135 million, covering roughly 60% of the capacity build?out at its Herøya facility in Norway. Nel expects to reach 500 megawatts of installed capacity there by the end of this year, with longer?term ambitions to scale to 1 gigawatt after a final investment decision in December 2025, and eventually 4 GW annually.

To preserve cash while it waits for demand to materialise, management has taken a hatchet to costs. Nel cut a quarter of its workforce, reducing headcount to around 300 employees, and the Q1 numbers reflect the strained state of the business. Revenue slipped to 148 million Norwegian kroner, the operating loss stood at minus 100 million kroner, and order intake collapsed to a meagre 85 million kroner. On the bright side, the balance sheet still holds 1.4 billion kroner in cash, enough to fund operations through the end of the year.

The central question hanging over the stock is whether the new technology will translate into commercial contracts. The order book has withered while Nel was developing the platform, and the management team has pinned its hopes on the second half of the year, when the industry expects a wave of final investment decisions. If those decisions favour Nel’s new offering, the stock’s rally could find a fundamental footing. If not, the current valuation — already far above the analyst consensus — could look exposed.

Nel finds itself in the middle tier of what one sector observer has called a “three?speed hydrogen market”. At the front, companies like ITM Power and Ceres Power have delivered triple?digit annual gains backed by tangible scaling and revenue upgrades. At the rear, names such as HydrogenPro struggle with rapidly shrinking cash piles and binary project outcomes. Nel sits in between: a genuine technology innovation that could upend industry cost structures, but without the order confirmations that would convince the doubters. The next 90 days will tell whether the platform is a game?changer or a brilliant product nobody buys.